1. Home
  2. TOWN vs NAMS Comparison

TOWN vs NAMS Comparison

Compare TOWN & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TowneBank

TOWN

TowneBank

HOLD

Current Price

$35.94

Market Cap

3.3B

Sector

Finance

ML Signal

HOLD

Logo NewAmsterdam Pharma Company N.V.

NAMS

NewAmsterdam Pharma Company N.V.

HOLD

Current Price

$28.12

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOWN
NAMS
Founded
1998
2019
Country
United States
Netherlands
Employees
2976
100
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TOWN
NAMS
Price
$35.94
$28.12
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$46.75
AVG Volume (30 Days)
368.8K
846.0K
Earning Date
04-22-2026
05-06-2026
Dividend Yield
3.02%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$35.63
$17.96
Revenue Next Year
$5.18
$540.65
P/E Ratio
$16.23
N/A
Revenue Growth
N/A
N/A
52 Week Low
$31.91
$16.79
52 Week High
$37.86
$42.00

Technical Indicators

Market Signals
Indicator
TOWN
NAMS
Relative Strength Index (RSI) 60.57 35.47
Support Level $34.69 $23.48
Resistance Level $37.22 $37.25
Average True Range (ATR) 0.83 1.83
MACD 0.01 -0.64
Stochastic Oscillator 69.19 3.94

Price Performance

Historical Comparison
TOWN
NAMS

About TOWN TowneBank

Towne Bank is a financial services company serving individuals, commercial enterprises and professionals, offering retail and commercial banking services in Virginia and North Carolina. The company has four reportable segments: Banking, which provides loan and deposit services, commercial mortgage brokerage, and investment and asset management services; Mortgage, which originates mortgage loans principally sold in the secondary market through purchase commitments from investors; Resort Vacation Management, which provides residential resort property management services; and Insurance, which provides property, casualty, life and health insurance solutions for businesses, individuals and community organizations through a variety of carriers.

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.

Share on Social Networks: